(NERV) - Earnings & Price History

NERV: - 6.05, $272.06M, -0.25 (-3.97%)

Sector: Healthcare - Industry: Biotechnology

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. The companys lead product candidate includes MIN-101, a compound for the treatment of patients with schizophrenia that is in Phase IIb clinical trial. Its products in Phase IIa clinical trial comprise MIN-117, a compound for the treatment of patients suffering from major depressive disorder; and MIN-202, a selective orexin 2 receptor antagonist for the treatment of primary and comorbid insomnia. The company preclinical stage product includes MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinsons disease. It has a co-development and license agreement with Janssen Pharmaceutica, N.V. for the development of MIN-202. The company was formerl

Past NERV reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-13BMO-0.258.658.78.88.358.91.15%-1.70%-0.57%127.74K
2016-11-03BMO-0.219.4511.059.958.811.2-9.95%▲-5.03%-14.48%452.30K
2016-08-04BMO-0.311.2311.0211.3510.8311.452.99%-1.06%1.91%227.63K
2016-05-03BMO-0.336.576.326.46.276.971.27%2.66%3.96%157.16K
2016-03-14BMO-0.315.885.675.85.695.952.29%1.38%3.70%28.20K
2015-11-05-0.365.095.35.294.985.46-0.19%▲-3.78%-3.96%29.75K
2015-08-05-0.416.055.845.885.886.050.68%2.89%3.60%388
2015-05-07BMO-0.525.155.15.15.15.160.98%0.98%15.32K
2015-03-26AMC-0.465.295.365.635.25.695.04%-6.04%-1.31%89.68K
2015-02-05Minerva Neurosc-0.524.774.854.944.585.041.86%-3.44%-1.65%83.00K
2014-11-06AMCMinerva Neurosc-2.3-1.534.184.284.354.184.411.64%▲-3.91%-2.34%19.30K
2014-08-07AMCMinerva Neurosc-0.41-2.336.5176.266.266.85-10.57%3.99%-7.00%40.00K

Login | Register
Saturday Nov 17, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades